Market Newsdesk

January 14, 2025 9:31 am

Calumet Announces $65 Million At-the-Market Equity Offering Program

PR Newswire

INDIANAPOLIS
, Jan. 14, 2025 /PRNewswire/ — Calumet, Inc. (NASDAQ: CLMT) (the “Company” or “Calumet”) today announced that the Company has filed a prospectus supplement with the U.S. Securities and Exchange Commission (the “SEC”) establishing an at-the-market equity offering program (the “ATM Program”) under which it may issue and sell, from time to time, shares of its common stock having an aggregate gross sales price of up to $65 million (the “Offered Shares”). Calumet intends to use the net proceeds from the ATM Program for general corporate purposes, which may include, among other things, repayment of indebtedness, working capital and capital expenditures.

Pursuant to the ATM Program, Calumet may issue and sell, at its discretion, the Offered Shares to the public from time to time, at the market prices prevailing at the time of sale, at prices related to the prevailing market prices or at negotiated prices, in each case on or through the Nasdaq Global Select Market or any other national securities exchange where the Offered Shares may be traded, and, as a result, prices at which the Offered Shares are sold may vary among purchasers and during the period of any distribution.

Pursuant to the terms of the equity distribution agreement (the “Equity Distribution Agreement”), dated January 14, 2025, between Calumet and BMO Capital Markets Corp. (the “Sales Agent”), sales of the Offered Shares, if any, under the ATM Program will be made in sales deemed to be “at the market offerings” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The Sales Agent may also sell the Offered Shares by any other method agreed in writing between Calumet and the Sales Agent and permitted by applicable law, including, without limitation, as block transactions. Subject to the terms and conditions of the Equity Distribution Agreement, the Sales Agent will use its commercially reasonable efforts, consistent with normal trading and sales practices and in accordance with applicable law and regulations, to sell on Calumet’s behalf all of the Offered Shares designated by Calumet pursuant to a placement notice. There is no minimum amount of funds that must be raised under this offering.

The offering is being made pursuant to a prospectus supplement dated January 14, 2025 to the Company’s base prospectus included in its registration statement on Form S-3 filed with the SEC on January 14, 2025. Before making an investment in the Offered Shares, potential investors should read the prospectus supplement and the accompanying base prospectus for more information about Calumet and the ATM Program. Copies of the prospectus supplement, the accompanying base prospectus and the Equity Distribution Agreement are available on the SEC’s website at www.sec.gov. Potential investors can request copies of the prospectus supplement and the accompanying base prospectus from the Sales Agent by contacting: BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 W 42nd Street, 32nd Floor, New York, NY 10036 or by email at [email protected].

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of these securities, nor shall there be any sale of these securities, in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About Calumet

Calumet, Inc. (NASDAQ: CLMT) manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. Calumet is headquartered in Indianapolis, Indiana and operates twelve facilities throughout North America.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements and information in this press release may constitute “forward-looking statements.” The words “will,” “may,” “intend,” “believe,” “expect,” “outlook,” “forecast,” “anticipate,” “estimate,” “continue,” “plan,” “should,” “could,” “would,” or other similar expressions are intended to identify forward-looking statements, which are generally not historical in nature. The statements discussed in this press release that are not purely historical data are forward-looking statements, including, but not limited to, the statements regarding (i) the potential distribution of the Offered Shares pursuant to the ATM Program, (ii) the aggregate gross sales price of the Offered Shares which may be issued pursuant to the ATM Program and (iii) the expected use of net proceeds, if any, from the ATM Program. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. While our management considers these assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements. For additional information regarding known material risks, uncertainties and other factors that can affect future results, please see our filings with the SEC, including the risk factors and other cautionary statements in the latest Annual Report on Form 10-K of Calumet Specialty Products Partners, L.P. (the “Partnership”) and other filings with the SEC by the Company and the Partnership. We undertake no obligation to publicly update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required by applicable law.

View original content:https://www.prnewswire.com/news-releases/calumet-announces-65-million-at-the-market-equity-offering-program-302350567.html

SOURCE Calumet, Inc.

January 14, 2025 9:30 am

Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers

VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA’s War on Smoking

MOCKSVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, was featured today in a Washington Post news story (https://www.washingtonpost.com/health/2025/01/14/cigarettes-low-nicotine-regulation-biden/) addressing new federal policy activities that could reduce the health harms of smoking. The article focuses on a recent U.S. Food and Drug Administration policy proposal to mandate reduced nicotine content in cigarettes, which recently cleared review by the U.S. Office of Management and Budget on January 3, 2025.

“While we are in the final days of the Biden administration, this policy – which may be the most ambitious and impactful smoking harm reduction policy in a generation – was originally jumpstarted in 2017 during the first Trump administration by then FDA Commissioner Scott Gottlieb, a major proponent of smoking harm reduction,” said Larry Firestone, Chief Executive Officer of 22nd Century Group. “We are excited to see federal policy continue to progress even as we continue to roll out the first reduced nicotine cigarettes commercially across the U.S., demonstrating that adult smokers who want this product can use it effectively to control their nicotine intake.”

The proposal is based on decades of clinical research underpinned by reduced nicotine content cigarettes manufactured by 22nd Century showing that adult smokers can control their smoking when using a reduced nicotine content cigarette in place of conventional nicotine cigarettes currently sold by the major tobacco companies. 22nd Century’s VLN branded low nicotine cigarettes are the first and only combustible tobacco products to receive authorization by the FDA under its Modified Risk Tobacco Product designation and available at more than 5,000 stores across the country.

“While this may be a David-and-Goliath story, we are quickly moving ahead with an increasing number of retailers who are interested in not only putting our VLN products on the shelf, but also stocking their own or other brands of reduced nicotine cigarettes that we can manufacture or license using our proprietary tobacco strains, creating a new category in the market. Using VLN products mirrors the growing non-alcoholic beer and spirits segments in adult beverage as consumers seek alternatives to traditional products in those categories.”

“The FDA originally estimated in the first five years alone that 13 million smokers could benefit under this policy, a tremendous figure for public health across the country. Big Tobacco has tried to question whether this policy could be achieved on a commercial basis or suggest contraband cigarettes would be a major issue. 22nd Century has demonstrated that not only is this policy commercially viable, it is also effective at the primary goal – controlling nicotine intake and cutting smoking activity,” said Firestone.
About 22nd Century Group, Inc.

22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption.

We created our flagship product, the VLN^® cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption. VLN^® cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether.

Our wholly owned subsidiaries include a leading cigarette manufacturer that produces all VLN® products and provides turnkey contract manufacturing for other tobacco brands both domestically and internationally. The 60,000 square foot facility in Mocksville, North Carolina has the capacity to produce more than 45 million cartons of combusted tobacco products annually with additional space for expansion.

Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets.

VLN^® and Helps You Smoke Less^® are registered trademarks of 22nd Century Limited LLC.

Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.

Learn more about VLN^® at tryvln.com.

Cautionary Note Regarding Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as “anticipate,” “believe,” “consider,” “continue,” “could,” “estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,” “intend,” “likely,” “may,” “plan,” “potential,” “predict,” “preliminary,” “probable,” “project,” “promising,” “seek,” “should,” “will,” “would,” and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in “Risk Factors” in the Company’s Annual Report on Form 10-K filed on March 28, 2024, and in the Company’s Quarterly Reports filed on May 15, 2024, August 13, 2024, and November 11, 2024. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.

Investor Relations & Media Contact

Matt Kreps
Investor Relations
22nd Century Group
[email protected]
214-597-8200

January 14, 2025 9:28 am

Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles

Henry Schein Opens Henry Schein Cares Foundation 2025 Relief Fund and Commits Up to $300,000 in Cash and Essential Health Care Supplies to Support the City of Los Angeles

MELVILLE, N.Y.–(BUSINESS WIRE)–
Henry Schein, Inc. (Nasdaq: HSIC) today announced the opening of the Henry Schein Cares Foundation 2025 Relief Fund to support the Los Angeles area fires. Contributions will support the provision of critical health care supplies and resources to help people impacted by the wildfires throughout the city.

The Company and Henry Schein Cares Foundation will donate an initial $25,000 each to support relief efforts and the Company will match Team Schein Member (TSM) contributions up to another $50,000, for a cash total of up to $150,000. The Company will also donate essential health care supplies up to an initial amount of $150,000 to its partner relief organizations operating on the ground, bringing Henry Schein’s total commitment to as much as $300,000.

“The wildfires in Los Angeles are devastating to watch, and Team Schein stands in solidarity with everyone who has been affected as well as all the first responders and individuals who are committed to supporting relief efforts,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “In response to this emergency, we will partner with trusted and long-standing relief and recovery charitable partners to ensure the availability of the critical supplies and resources required to provide health care within affected communities. Team Schein remains committed to helping health happen in light of this evolving situation.”

Anyone who wishes to contribute to the 2025 Relief Fund can donate by visiting www.henryschein.com/foundationdonate and selecting “2025 Relief Fund” for the gift designation.

For dental and medical professionals impacted by the wildfires and in need of assistance, please call 800-999-9729, or click here to learn about the Company’s Customer Emergency Support Hotline.

The Henry Schein Customer Emergency Support Hotline remains open throughout the year to help practitioners during preparation and recovery from emergencies. The Emergency Preparedness Guide for Henry Schein Customers provides steps to help practices minimize the impact of a natural disaster and swiftly return to operations. To help meet the challenges of rebuilding a practice in the wake of a natural disaster, practitioners can download the Emergency Recovery Guide for Office-Based Health Care Practitioners. For more information about Henry Schein’s emergency preparedness and relief resources for practices, please click here.

About The Henry Schein Cares Foundation

Established in 2008, The Henry Schein Cares Foundation, Inc., fosters a rich culture of giving back to society and serving others. The Foundation advocates and supports efforts to advance health equity and empower health care professionals to promote a healthier tomorrow for all people around the world through advancing access to care, promoting a holistic model of health care, building capacity to empower health care professionals, and catalyzing innovative models for emergency preparedness & response.

The Foundation is a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. To learn more about the work of the Henry Schein Cares Foundation, visit www.henryschein.com/hscaresfoundation.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company’s sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250114738429/en/

Ann Marie Gothard

Vice President, Global Corporate Media Relations

[email protected]

+1 (631) 390-8169

KEYWORDS: United States North America California New York

INDUSTRY KEYWORDS: Philanthropy Health Fund Raising Dental Foundation General Health

MEDIA:

Logo

January 14, 2025 9:28 am

Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging

The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians with access to technology advances and innovations. It will also drive ongoing, comprehensive training and education, fostering future healthcare professionals representing the diverse communities they serve.
Sutter Health, one of the top integrated health delivery systems in the country with more than 300 facilities, serves more than 3.5 million patients and estimates it will be able to serve tens of thousands more patients annually through the expansion this collaboration enables.
Care Alliance with Sutter Health is one of GE HealthCare’s largest ever enterprise strategic partnerships, and evolution of 20-year relationship between two organizations.

SACRAMENTO, Calif.–(BUSINESS WIRE)–
Sutter Health and GE HealthCare (Nasdaq: GEHC) today announced a seven-year strategic enterprise partnership, known as a Care Alliance, that aims to increase access to innovative imaging services and create a more seamless and coordinated experience for clinicians and patients across the Sutter Health system. The long-term collaboration will increase access to essential diagnostic care across California, providing patients with advanced technology in their own communities that can help enable quicker appointment scheduling, accelerated diagnostic imaging scan results, early diagnoses, greater convenience, and more consistent and timely care. This Care Alliance marks one of GE HealthCare’s largest ever enterprise strategic partnerships.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250114027612/en/

For Sutter, this alliance will help achieve faster access to novel equipment and technology solutions, as well as provide an innovative service delivery model with enhanced, reliable equipment availability. It is grounded in key goals, including expanded access to care, improved patient experience, more consistency regardless of care location, increased patient capacity, greater system integration and interoperability, and a timely refresh of needed equipment. It centers on several areas of collaboration, including optimized technology, an innovative service delivery model, advancing service line care at destination centers of excellence and digital integration.

“This strategic partnership is rooted in our commitment to providing innovative, high-caliber care to our 3.5 million patients across Northern California and the Central Coast,” said Warner Thomas, president and CEO of Sutter Health. “We’re responding to what we’ve heard from our physicians and making comprehensive upgrades with the latest technology to boost our capacity and expand access points. This collaboration ensures that no matter where patients enter the Sutter Health system, they’ll receive seamless and coordinated care.”

The first key focus area of the Care Alliance is an accelerated technology program across the Sutter Health system that will focus on some of the most advanced AI-powered imaging technology and digital solutions available to patients, including PET/CT, SPECT/CT, MRI, CT, X-ray, nuclear medicine and ultrasound. GE HealthCare’s interventional, mammography, diagnostic cardiology, maternal and infant care and anesthesia solutions will also be included in Sutter Health’s ambulatory care centers, helping to address the growing need for care outside of the traditional hospital setting. This comprehensive technology refresh covers the breadth of GE HealthCare’s portfolio of solutions, providing clinicians with innovative options to meet changing patient needs more efficiently and quickly.

“We are committed to support Sutter Health in its mission and have deep respect for their openness to a collaboration that meets the heart of their needs,” said Catherine Estrampes, U.S. and Canada president & CEO at GE HealthCare. “This Care Alliance is a customized, clinician-focused approach aligned with our shared goals. It was jointly designed with expert assessment of how we provide our latest imaging technology in the right settings to serve patients most efficiently throughout their care journey, closer to home. We look forward to supporting Sutter Health physicians and clinicians in delivering enhanced patients’ outcomes.”

Imaging and ultrasound solutions, enabled by digital and AI advancements, will be implemented across the entire healthcare system over several years, reducing variation and providing the innovation clinicians need to best serve patients. Innovative new solutions include GE HealthCare’s Omni Legend PET/CT, StarGuide SPECT/CT and Vscan Air™ SL ultrasound with Caption AI™ software. Notably, GE HealthCare’s AIR™ Recon DL MR image reconstruction will be deployed and utilizes deep learning algorithms to improve image quality and MRI scan times. By optimizing image reconstruction AIR™ Recon DL reduces artifacts, and enhances image clarity and scan times, enabling clinicians to obtain high-quality diagnostic images while improving patient comfort and workflow efficiency.

The strategic partnership also supports Sutter Health’s larger access strategy, which includes opening dozens of new care sites across Northern California in the next few years. Additionally, it will further support the health system’s expansion of advanced service lines and destination centers of excellence including areas such as heart and vascular care, cancer care and neurosciences. This includes access to new technology and digital optimization to expand clinical procedures and services, helping enable precise, high-quality patient care from early screening to diagnosis to treatment to monitoring. For example, Sutter Health plans to build a new cancer center on Sutter’s Memorial Medical Center campus in the California Central Valley and recently announced two new flagship campuses in Silicon Valley with specialty care focuses. Potential future areas of enhanced services across the Sutter Health system could include mental health, orthopedics, women’s health and pediatrics.

Sutter Health will adopt technology at a more rapid pace with an accelerated upgrade schedule, including the latest software releases to prevent obsolescence and keep technologies current over the long-term. The service delivery model will help ensure consistent operations and minimize unexpected disruptions—with patient safety, efficiency and reliability in mind.

The agreement will also include significant investment in Sutter Health’s workforce development programs to include ongoing training and education for technologists, nurses and physicians through Sutter Health University and other learning opportunities, which includes supporting the next generation of clinicians who are reflective of the communities they serve. GE HealthCare plans to assist Sutter Health in the design of a scalable workforce and talent development program that includes talent pathway community outreach, collaborations with radiologic technologist schools, as well as talent acquisition, development and retention, including leadership and clinical learning journeys. The program will aim at addressing the critical clinician shortage and support healthcare providers’ clinical staffing needs.

About Sutter Health

Sutter Health is a not-for-profit healthcare system dedicated to providing comprehensive care throughout California. Committed to health equity, community partnerships, and innovative, high-quality patient care, Sutter Health is pursuing a bold new plan to reach more people and make excellent healthcare more connected and accessible. Currently serving nearly 3.5 million patients, thanks to our dedicated team of more than 57,000 employees and clinicians, and 12,000+ affiliated physicians, with a unified focus on expanding care to serve more patients.

Sutter delivers exceptional and affordable care through its hospitals, medical groups, ambulatory surgery centers, urgent care clinics, telehealth, home health, and hospice services. Dedicated to transforming healthcare, at Sutter Health, getting better never stops.

Learn more about how Sutter Health is transforming healthcare at sutterhealth.org and vitals.sutterhealth.org.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250114027612/en/

Sutter Health Media Contact:

Liz Madison

[email protected]

GE HealthCare Media Contact:

Sara Pottle

M +1 626 390 7620

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Hardware Health Technology Data Management Other Health Technology Practice Management Managed Care Oncology General Health Artificial Intelligence Other Technology Science Software Other Science Research Health

MEDIA:

Logo

January 14, 2025 9:23 am

Ideal Power Announces Plans for Upcoming Investor Conferences

PR Newswire

Emerging Growth Virtual Conference on January 16, 2025
Planet MicroCap Showcase in Las Vegas on April 23 and 24, 2025

AUSTIN, Texas
, Jan. 14, 2025 /PRNewswire/ — Ideal Power Inc. (Nasdaq: IPWR) (“Ideal Power,” the “Company,” “we,” “us” or “our”), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, today announced management’s plans for participation in upcoming investor conferences.

Emerging Growth Virtual Conference on January 16, 2025
Ideal Power plans to present at the Emerging Growth Virtual Conference on January 16 at 2:20 PM ET. The live, interactive webcast and slide presentation will be accessible on the Company’s Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing.

Planet MicroCap Showcase in Las Vegas on April 23 and 24, 2025
Ideal Power plans to participate at the Planet MicroCap Showcase in Las Vegas, NV on April 23 and 24. Ideal Power’s presentation webcast is on April 23, and its one-on-one investor meetings are on April 24. The Planet MicroCap Showcase is in partnership with MicroCapClub.

Ideal Power’s presentation webcast at the Planet MicroCap Showcase in Las Vegas is April 23 at 10:30 AM PT. The live, interactive webcast and slide presentation will be accessible on the Company’s Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing.

Planet MicroCap Showcase attendees in Las Vegas are encouraged to register and request HERE a one-on-one meeting with Ideal Power on April 24.

About Ideal Power Inc.

Ideal Power (NASDAQ: IPWR) is the developer and innovative provider of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS/data center, solid-state circuit breaker and other industrial and military applications. The Company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN®) semiconductor technology. B-TRAN® is a unique double-sided bidirectional AC switch that delivers substantial performance improvements over today’s conventional power semiconductors. Ideal Power’s B-TRAN® can reduce conduction and switching losses, complexity of thermal management and operating cost in AC power switching and control circuitry. For more information, visit the Company’s website at www.IdealPower.com, on LinkedIn, on Twitter, and on Facebook.

Ideal Power Investor Relations Contact

Jeff Christensen

Darrow Associates Investor Relations
[email protected]
703-297-6917

View original content to download multimedia:https://www.prnewswire.com/news-releases/ideal-power-announces-plans-for-upcoming-investor-conferences-302349875.html

SOURCE IDEAL POWER INC.

January 14, 2025 9:21 am

Genius Group announces $33 Million Rights Offering to increase Bitcoin Treasury

SINGAPORE, Jan. 14, 2025 (GLOBE NEWSWIRE) —

Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, announced today that its Board of Directors (the “Board”) has approved a plan to proceed with a $33 million rights offering for the Company’s ordinary shares (the “Rights Offering”), with 100% of net proceeds to be used to purchase Bitcoin for the Company’s Bitcoin Treasury. The Rights Offering will be made only by means of a prospectus supplement, and this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, any of securities.

SUMMARY OF THE TERMS OF THE RIGHTS OFFERING

	●	Each shareholder will receive one transferable right (the “Right”) for each ordinary share held on January 24, 2025 (the “Record Date”). The number of Rights to be issued to a shareholder as of the close of business on the Record Date will be rounded up to the nearest number of Rights. The Company’s ordinary shares are expected to trade “Ex-Rights” on the NYSE American beginning on January 24, 2025.
	●	Each Right entitles the holder to purchase one ordinary share of the Company (the “Basic Subscription Right”) at the subscription price of $0.50 per whole ordinary share (the “Subscription Price).
	●	Rights holders who fully exercise their Basic Subscription Rights will be entitled to subscribe for additional ordinary shares of the Company that remain unsubscribed as a result of any unexercised Basic Subscription Rights (the “Over-subscription Right”). The Over-subscription Right allows a rights holder to subscribe for additional ordinary shares of the Company at the subscription price on a pro rata basis. Any record date shareholder who sells any Rights will not be eligible to participate in the over-subscription privilege.
	●	Rights holders who choose not to exercise their Rights may sell their Rights. Trading in the Rights on the NYSE American is expected to begin on a “when-issued” basis on January 23, 2025 under the symbol “GNS RTWI” and trade on a “regular way” basis on January 27, 2025 under the symbol “GNS RT” and continue until the close of trading on the NYSE American on February 13, 2025 (or if the offer is extended, on the business day immediately prior to the extended expiration date).
	●	The Rights Offering expires at 4.30 p.m., Eastern Time, on February 14, 2025 (the “expiration date”) unless extended by the Company.

SUMMARY OF THE USE OF FUNDS: BITCOIN TREASURY

	●	The Company plans to use 100% of the net proceeds of the Rights Offering to purchase Bitcoin for its Bitcoin Treasury. The Company anticipates that, in the event that the Rights Offering is fully subscribed, the proceeds will be up to $33 million.
	●	The Company also plans to pursue one or more additional loan financings of up to, in the aggregate, $20 million. If the Company is successful in raising the maximum amount in the Rights Offering and through additional loans, the Company’s Bitcoin Treasury will increase from approximately $35 million in Bitcoin to $86 million in Bitcoin.

FOUNDER & MANAGEMENT PARTICIPATION

	●	The Founder and CEO of the Company, Roger Hamilton, intends to submit an application to acquire 500,000 additional newly issued shares of the Company, as approved by the Board on August 9, 2024. The Board approved a plan in which Mr. Hamilton would have the right to purchase one million shares (adjusted from ten million shares after the Company’s reverse stock split) at a per share price equal to 105% of the closing price on the prior trading day to the date of purchase. On October 8, 2024, Mr. Hamilton acquired 500,000 shares, and has notified the Company that he would purchase the remaining 500,000 shares on January 15, 2025 in accordance with the terms of the plan.
	●	Following the acquisition of these additional newly issued shares, subject to the closing share price on January 14, 2025, Mr. Hamilton will own an estimated 6.8 million shares of the Company, representing approximately 10.3% of the 66 million issued shares in the Company. Mr. Hamilton has notified the Company that he would fully subscribe to his rights under this Rights Offering, which will amount to rights to an additional 6.8 million shares on the same terms as all shareholders on the Record Date as detailed above.

The subscription agent for the Rights Offering will send a rights certificate to each registered holder of the Company’s ordinary shares as of the close of business on the record date, based on the Company’s stockholder registry maintained at the transfer agent for its ordinary shares. Holders of ordinary shares in “street name” through a brokerage account, bank, or other nominee will not receive a physical rights certificate, and instead, such holders must instruct their broker, bank, or nominee whether or not to exercise subscription rights on their behalf. For any questions or further information about the Rights Offering, please call Campaign Management LLC, the proposed information agent for the Rights Offering, at +1 (855) 264-1527.

The Rights Offering will be made pursuant to the Company’s effective shelf registration statement on Form S-3 (Reg. No.333-280600) on file with the Securities and Exchange Commission (the “SEC”) and a prospectus supplement to be filed with the SEC prior to the commencement of the Rights Offering.

The information herein is not complete and is subject to change. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the rights, ordinary shares or any other securities, nor will there be any sale of the rights, ordinary shares or any other securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. This document is not an offering, which can only be made by a prospectus. The base prospectus contains this and additional information about the Company and the prospectus supplement will contain this and additional information about the Rights Offering, and should be read carefully before investing. For any questions or further information about the Rights Offering, or to obtain a prospectus supplement and the accompanying prospectus, when available, please call Campaign Management LLC, the proposed information agent for the Rights Offering, at +1 (855) 264-1527.

RIGHTS OFFERING INVESTOR CALL

The Company will hold a live webcast and investor call to discuss the Rights Offering on Wednesday, January 15, 2025 at 5.00 pm., Eastern Time. Certain financial information relating to the Company’s 2025 outlook and Bitcoin Treasury strategy will be discussed on the webcast and is included in the prospectus supplement to be filed related to the Rights Offering. Investors can attend the Investor call live by visiting https://www.geniusgroup.ai

About Genius Group

Genius Group (NYSE: GNS) is a Bitcoin-first business delivering AI powered, education and acceleration solutions for the future of work. Genius Group serves 5.4 million users in over 100 countries through its Genius City model and online digital marketplace of AI training, AI tools and AI talent. It provides personalized, entrepreneurial AI pathways combining human talent with AI skills and AI solutions at the individual, enterprise and government level. To learn more, please visit www.geniusgroup.net.

For more information, please visit https://www.geniusgroup.net/

Forward-Looking Statements

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by the use of words such as “may,” “will”, “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 20-F, as may be supplemented or amended by the Company’s Reports of a Foreign Private Issuer on Form 6-K and prospectus supplement to Form F-3 to be filed with respect thereto. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise. No information in this press release should be construed as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

Contacts

MZ Group – MZ North America
(949) 259-4987
[email protected]
www.mzgroup.us

January 14, 2025 9:21 am

Diana Shipping Inc. Announces Direct Continuation of Time Charter Contract for M/V Semirio with Solebay and for M/V DSI Aquila with Western Bulk

ATHENS, Greece, Jan. 14, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has extended the time charter contract with Solebay Shipping Cape Company Limited, Hong Kong, for one of its Capesize dry bulk vessels, the m/v Semirio. The gross charter rate is US$16,650 minus a 5% commission paid to third parties, for a period until minimum February 15, 2026 up to maximum April 15, 2026. The new charter period is expected to commence on February 4, 2025. The m/v Semirio is currently chartered, as previously announced, at a gross charter rate of US$14,150 per day, minus a 5.00% commission paid to third parties.

The “Semirio” is a 174,261 dwt Capesize dry bulk vessel built in 2007.

The Company also announced that, through a separate wholly-owned subsidiary, it has extended the time charter contract with Western Bulk Carriers AS, for one of its Ultramax dry bulk vessels, the m/v DSI Aquila. The gross charter rate is US$12,250 per day, minus a 5% commission paid to third parties, for a period of minimum five (5) months to about seven (7) months. The new charter period is expected to commence on January 23, 2025. The m/v DSI Aquila is currently chartered, as previously announced, at a gross charter rate of US$12,500 per day, minus a 5.00% commission paid to third parties.

The “DSI Aquila” is a 60,309 dwt Ultramax dry bulk vessel built in 2015.

The employment extensions of “Semirio” and “DSI Aquila” are anticipated to generate a total of approximately US$7.52 million of gross revenue for the minimum scheduled period of the time charters.

Diana Shipping Inc.’s fleet currently consists of 38 dry bulk vessels: 4 Newcastlemax, 8 Capesize, 5 Post-Panamax, 6 Kamsarmax, 6 Panamax and 9 Ultramax. The Company also expects to take delivery of two methanol dual fuel new-building Kamsarmax dry bulk vessels by the second half of 2027 and the first half of 2028, respectively. As of today, the combined carrying capacity of the Company’s fleet, excluding the two vessels not yet delivered, is approximately 4.2 million dwt with a weighted average age of 11.29 years. A table describing the current Diana Shipping Inc. fleet can be found on the Company’s website, www.dianashippinginc.com. Information contained on the Company’s website does not constitute a part of this press release.

About the Company

Diana Shipping Inc. is a global provider of shipping transportation services through its ownership and bareboat charter-in of dry bulk vessels. The Company’s vessels are employed primarily on short to medium-term time charters and transport a range of dry bulk cargoes, including such commodities as iron ore, coal, grain and other materials along worldwide shipping routes.

Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts.

The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect,” “pending” and similar expressions identify forward-looking statements.

The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, Company management’s examination of historical operating trends, data contained in the Company’s records and other data available from third parties. Although the Company believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies that are difficult or impossible to predict and are beyond the Company’s control, the Company cannot assure you that it will achieve or accomplish these expectations, beliefs or projections.

In addition to these important factors, other important factors that, in the Company’s view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for dry bulk shipping capacity, changes in the Company’s operating expenses, including bunker prices, drydocking and insurance costs, the market for the Company’s vessels, availability of financing and refinancing, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, including risks associated with the continuing conflict between Russia and Ukraine and related sanctions, potential disruption of shipping routes due to accidents or political events, including the escalation of the conflict in the Middle East, vessel breakdowns and instances of off-hires and other factors. Please see the Company’s filings with the U.S. Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Corporate Contact:
Ioannis Zafirakis
Director, Chief Financial Officer,
Chief Strategy Officer, Treasurer and Secretary
Telephone: + 30-210-9470-100  
Email: [email protected]
Website: www.dianashippinginc.com
X: @Dianaship

Investor and Media Relations:
Edward Nebb
Comm-Counsellors, LLC
Telephone: + 1-203-972-8350
Email: [email protected]

January 14, 2025 9:21 am

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

NATICK, Mass.–(BUSINESS WIRE)–
Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a subscription agreement with funds affiliated with RTW Investments, LP (“RTW”) for the purchase and sale of 841,751 shares of the Company’s common stock in a private placement at a purchase price of $2.97 per share. The private placement is expected to result in gross proceeds of $2.5 million and extend the Company’s runway through early 2026. The subscription agreement also includes an option to fund up to an additional $10 million in subsequent tranches. The private placement is expected to close on or about January 15, 2025, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the private placement for working capital and other general corporate purposes.

The Company also announced preliminary unaudited financial results for the fourth quarter and fiscal year 2024. Preliminary unaudited revenue for the fourth quarter of 2024 is expected to be approximately $5.6 million and full year revenue to be approximately $32 million, in line with previously issued guidance. Procedure volume growth for the full year, as estimated by new app users and excluding France, is expected to be approximately 4%, higher than previously issued guidance.

“We are pleased with our preliminary unaudited results from the fourth quarter, which put us in line with our previously issued guidance for revenue and ahead for procedure volume while restructuring our business so that we can grow more profitably and sustainably in the future,” said Dr. Shantanu Gaur, Founder and Chief Executive Officer. “On the heels of our results from the AUDACITY trial, we believe this private placement from RTW provides us the runway we need to execute our 2025 plan. Our 2025 plan includes scaling our new commercial strategy, advancing the Allurion Balloon through the FDA approval process, setting the company up for a profitable 2026, expanding our digital business lines, and resuming commercialization in France. I believe 2025 will be a pivotal year for Allurion with these potential catalysts ahead of us.”

Roth Capital Partners is acting as the sole financial advisor for the offering.

The securities sold in the private placement are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state or other applicable jurisdiction’s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less^TM gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan. The Allurion Gastric Balloon is an investigational device in the United States.

For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.

Estimated Preliminary Results for the Fourth Quarter and Fiscal Year Ended December 31, 2024 (Unaudited)

Set forth above are certain estimated preliminary financial results and other key business metrics for the fourth quarter and fiscal year ended December 31, 2024. These estimates are based on the information available to us at this time. Our actual results may vary from the estimated preliminary results presented here due to the completion of our financial closing procedures, final adjustments and other developments that may arise between now and the time the financial results for the quarter and year ended December 31, 2024 are finalized. The estimated preliminary financial results and other key business metrics have not been audited or reviewed by our independent registered public accounting firm. These estimates should not be viewed as a substitute for our full interim or annual financial statements. Accordingly, you should not place undue reliance on this preliminary data.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the U.S. federal and state securities laws. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “target,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions and include statements regarding the expected completion, timing and size of the private placement, the anticipated use of proceeds of the private placement, Allurion’s preliminary unaudited 2024 results for the fourth quarter and fiscal year ended December 31, 2024, including revenue generation and growth, and procedural volume growth, alignment of such results with full year 2024 expectations, the Company’s cash runway, ability to advance the FDA process for the Allurion Balloon and achieve profitability in 2026, expand commercialization of the digital business, resume commercialization in France, and other statements about future events that reflect the current beliefs and assumptions of Allurion’s management based on information currently available to them and, as a result, are subject to risks and uncertainties. Forward-looking statements are predictions, projections and other statements about future events that reflect the current beliefs and assumptions of Allurion’s management based on information currently available to them and, as a result, are subject to risks and uncertainties. Many factors could cause actual future results or developments to differ materially from the forward-looking statements in this press release, including but not limited to (i) the ability of Allurion to obtain regulatory approval for and successfully commercialize the Allurion Program, (ii) the timing of and results from its clinical studies and trials, (iii) the evolution of the markets in which Allurion competes and the rise of GLP-1 drugs, (iv) the ability of Allurion to defend its intellectual property and satisfy regulatory requirements, (v) the impact of the COVID-19 pandemic, Russia-Ukraine war and Israel-Hamas war on Allurion’s business, (vi) Allurion’s expectations regarding its market opportunities, (vii) the outcome of any legal proceedings against Allurion, (viii) the risk of economic downturns and a changing regulatory landscape in the highly competitive industry in which Allurion operates, and (ix) uncertainties related to market conditions and the completion of the private placement on the anticipated terms or at all. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K filed on March 26, 2026 and Amendment No. 1 thereto filed on April 29, 2024, the Company’s Quarterly Report on Form 10-Q filed on November 13, 2024 and other documents filed by Allurion from time to time with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Allurion assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Allurion does not give any assurance that it will achieve its expectations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250114242379/en/

Global Media

Hannah Lindberg

[email protected]

Investor Contact

Mike Cavanaugh, Investor Relations

ICR Westwicke

(617) 877-9641

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: General Health Health Artificial Intelligence Medical Devices Health Technology Technology Apps/Applications Fitness & Nutrition

MEDIA:

Logo

January 14, 2025 9:18 am

Rocket Companies Unifies Under the ‘Rocket’ Brand with New Visual Identity

PR Newswire

The announcement marks the first phase of Rocket’s brand restage, set to be fully revealed during the company’s return to the Super Bowl

CLICK HERE TO FIND A GALLERY OF IMAGES SHOWING THE NEW VISUAL IDENTITY

DETROIT
, Jan. 14, 2025 /PRNewswire/ — Rocket Companies (NYSE: RKT), the Detroit-based fintech platform company consisting of mortgage, real estate and personal finance businesses, today unveiled a bold refresh to its brand identity. Designed to position Rocket as one of the most inclusive brands in America, the visual identity unifies many of the company’s services under the overarching “Rocket” brand, creating an influential end-to-end homeownership experience. As part of this effort, the company has acquired Rocket.com and introduced a reimagined logo, wordmark, typeface and color palette.

Rocket is rebranding key businesses as part of its evolution. Amrock, the national title producer, settlement provider and appraisal management company, will be changed to Rocket Close. Additionally, Amrock Title Insurance Company has relaunched as Rocket Title Insurance Company. Rocket Pro TPO has been renamed Rocket Pro, effective immediately, reflecting its commitment to supporting mortgage professionals nationwide. These changes simplify services and enhance Rocket’s mission to create a more inclusive and connected homeownership journey.

Rocket will reveal the next step in its brand transformation with a Super Bowl campaign, demonstrating how homeownership has the power to unite the nation – instilling a deep sense of pride and belonging. This is the first creative step in supporting Rocket’s mission to Help Everyone Home – redefining homeownership and empowering individuals to achieve the American dream. The new visual identity positions Rocket to engage with key growth demographics, including Hispanic, female, Veteran and first-time homebuyers, while continuing to resonate with its established audience.

“Homeownership is a fundamental building block of the American Dream. As the category leader, it is important that every aspect of the Rocket brand lives up to this iconic ideology,” said Jonathan Mildenhall, Chief Marketing Officer of Rocket Companies. “Owning a home creates identity, security, safety and purpose, not to mention the most proven asset class in terms of building generational wealth. This design evolution underscores our belief in the transformative power of homeownership and introduces Rocket as a timeless and iconic brand that empowers people to achieve their dreams.”

Building on Rocket’s strong legacy, the new design celebrates the modern American dream. A recent study found 92% of consumers aspire to purchase a home, underscoring its integral part in achieving the American dream and a pathway to a prosperous life¹. Key highlights of Rocket’s new visual identity include:

New ‘Halo’ Logo: The “halo” logo enhances Rocket’s brand recognition with a fresh design. As a universal symbol of trust, the circular form creates a protective arc, representing the journey to homeownership and the building of prosperity and generational wealth.
Refined Wordmark: Inspired by Rocket’s previous visual identity, the new wordmark has been redesigned for the future. The shift from block capitals to title case creates a friendlier, more approachable tone – while a custom sans-serif typeface mirrors the logo’s sleek geometry for consistency and improved accessibility for all audiences.
Custom Typefaces: Rocket introduced two bespoke typefaces to ensure a cohesive visual language across all touchpoints, from digital products to printed materials. Both typefaces honor Nick Gilbert, the late son of Rocket founder Dan Gilbert.
Refreshed ‘Red’: The signature Rocket Red color has been reimagined, evolving from a bright, intense tone to a softer, warmer shade that reflects the brand’s focus on compassion and inclusivity.
Authentic Community Portraits: Rocket’s refreshed visual storytelling features real clients in its photography, celebrating the diverse faces of modern America.

The new visual identity was created through a dynamic collaboration between Otherway, a leading design agency, and Rocket’s internal design and creative teams. Rocket and Otherway spent six months crafting the design system, refining it across thousands of internal and external touchpoints.

“Rocket’s new design elements embody our spirit and commitment to making homeownership accessible to all,” Mildenhall continued. “This is just the first of many steps Rocket will take in 2025 as we embark upon this significant companywide transformation. This refreshed identity celebrates the humanity and diversity of the homeownership journey, redefining what it truly means to own a home in today’s America.”

Tune into the Super Bowl on February 9, 2025, to see Rocket’s next step in its brand restage.

Forward Looking Statements

Some of the statements contained in this document are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are generally identified by the use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. These forward-looking statements reflect our views with respect to future events as of the date of this document and are based on our management’s current expectations, estimates, forecasts, projections, assumptions, beliefs and information. Although management believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. All such forward-looking statements are subject to risks and uncertainties, many of which are outside of our control, and could cause future events or results to be materially different from those stated or implied in this document. It is not possible to predict or identify all such risks. These risks include, but are not limited to, the risk factors that are described under the section titled “Risk Factors” in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings with the Securities and Exchange Commission (“SEC”). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this document and in our SEC filings. We expressly disclaim any obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable law.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based fintech platform company including mortgage, real estate and personal finance businesses Rocket Mortgage, Rocket Homes, Rocket Close, Rocket Money and Rocket Loans.

With more than 65 million call logs each year, 10 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership. Known for providing exceptional client experiences, J.D. Power has ranked Rocket Mortgage #1 in client satisfaction for primary mortgage origination and mortgage servicing a total of 22 times – the most of any mortgage lender.

For more information, please visit our Corporate Website or Investor Relations Website.

1. 2023 Fannie Mae Mortgage Understanding Study

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-unifies-under-the-rocket-brand-with-new-visual-identity-302350476.html

SOURCE Rocket Companies

January 14, 2025 9:18 am

Avient To Hold Fourth Quarter 2024 Conference Call

PR Newswire

CLEVELAND
, Jan. 14, 2025 /PRNewswire/ — Avient Corporation (NYSE: AVNT), an innovator of materials solutions, intends to release its fourth quarter 2024 earnings before the market opens on Thursday, February 13, 2025. The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Thursday, February 13, 2025.

The webcast can be viewed live at avient.com/investors, or by clicking on the webcast link here. Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the dial-in number and personal PIN. This information is required to access the conference call. The question and answer session will follow the company’s presentation and prepared remarks.

A recording of the webcast and the slide presentation will be available at avient.com/investors/events-presentations immediately following the conference call and will be accessible for one year.

About Avient

Our purpose at Avient Corporation (NYSE: AVNT) is to be an innovator of materials solutions that help our customers succeed, while enabling a sustainable world. Our local touch and customer engagement, combined with our global presence, allows us to serve customers with agility. We harness the collective strength of 9,000 employees worldwide to collaborate and build on each other’s ideas. In doing so, we innovate solutions that help our customers overcome their challenges or capitalize on opportunities provided by the fast-changing world and secular trends. Our expanding portfolio of offerings includes colorants, advanced composites, functional additives, engineered materials, and Dyneema®, the world’s strongest fiber™. By intersecting our broad portfolio of technologies with the product roadmaps of our customers, we help create differentiated and high-performance products that make the world better and more sustainable. Visit www.avient.com to learn more.

To access Avient’s news library online, please visit www.avient.com/news

View original content to download multimedia:https://www.prnewswire.com/news-releases/avient-to-hold-fourth-quarter-2024-conference-call-302350532.html

SOURCE Avient Corporation